Making Sense of Next-Generation Sequencing Data
Thermo Fisher announced today that it is acquiring the Life Technologies for $13.6 billion. Life Technologies had been looking to be acquired since the beginning of the year. And the acquisition news initially came out yesterday from a WSJ report. Confirming the report, Thermo Fisher announced the acquisition news early this morning. In a press [...]
It looks like the California based Life Technologies is about to be acquired by the Massachussets based Thermo Fisher. According to the report on Wall Street Journal tonight, Life Technologies and Thermo Fisher are in advanced stages of the acquisition talk and it is expected that the companies can announce the acquisition as early as [...]
Life Technologies announced that it will be launching a new Clinical Genomics company named “Claritas Genomics” in partnership with Boston Children’s Hospital. Claritas Genomics will develop diagnostic testings using next-generation genetics/genomics and the majority of Claritas Genomics will be owned by Boston Children’s hospital. The hospital’s CLIA certified genetic diagnostic lab and its personnel will [...]
What a difference a year makes for Illumina. Unlike last year, Illumina has started this year on a strong foot; Roche chief says Illumina is not a must have, but nice to have and Illumina announces the acquisition of Verinata Health, a non-invasive prenatal testing company. The year 2012 was a busy year for many personal [...]
Life Technologies made yet another acquisition and announced that it will be acquiring Compendia Bioscience, a cancer bioinformatics company based at Ann Arbor, MI. Compendia Bioscience was founded in 2006 by Arul Chinnaiyan, a Univ. Michigan professor and Dan Rhodes a researcher at U. Michigan. Compendia Bioscience was started with the mission of using genomic [...]
Life Technologies announced at Ion World event at San Francisco that it is beginning to ship Ion Proton sequencing system. Life Technologies will ship more than 100 Ion Proton sequencers to customers in September. Life Technologies’ Ion Proton, priced at $150,000, is a rapid genome-scale benchtop sequencer based on semi-conductor technologies that can sequence human [...]
Life Technologies, the leading global biotechnology company, sued Affymetrix’s eBioscience. In the lawsuit filed on the last week of August, Life technologies claimed that eBioscience products, mainly eBioscience’s eFluor® Nanocrystals (but not limited to), have violated its three patents (8,071,359, 8,071,360, 8,071,361) on “Semiconductor nanocrystal probes for biological applications and process for making and using such probes”. eFluor Nanocrystals are [...]
Life Technologies announced that it is acquiring Pinpoint Genomics and CLIA-Approved Lung Cancer Test for detecting early stage Non-Small Cell Lung Cancer Test. Pinpoint Genomics is Life Technologies’ second acquisition in the last two weeks. Earlier, Life Technologies acquired Navigenics, the personal genetics company. Pinpoint Genomics is Mountain View, CA based company founded by two [...]
Life Technologies Corp, the leading biotechnology and sequencing technology company head-quartered at Carlsbad, California, announced that it is acquiring Navigenics, San Francisco based personal genetics company. Navigenics was founded in 2006 by David Agus, M.D., a cancer specialist , and Dietrich Stephan, Ph.D., a human geneticist. Navigenics was one of the early companies to jump in to personal [...]
